Dosing and clinical outcomes of ruxolitinib in patients with myelofibrosis in a real‐world setting: Interim results of the Italian observational study (ROMEI)Massimo Breccia, Filíppo Gherlinzoni, Alessandra Malato et al.|Cancer|2025Cited by 10
In Ph+BCR-ABL1P210+ acute lymphoblastic leukemia the e13a2 (B2A2) transcript is prevalentMichele Baccarani, Francesco Passamonti, Ilaria Iacobucci et al.|Leukemia|2019Cited by 9